- Poster presentation
- Open Access
Molecular characterization of HTLV-1 and HTLV-2 and routes of virus transmission in HIV-infected patients from the southeastern and southern Brazil
© Magri et al; licensee BioMed Central Ltd. 2014
- Published: 7 January 2014
- Geographic Region
- Amino Acid Change
- Bioinformatic Tool
- Virus Transmission
- Frequent Nucleotide
Brazil is considered the country with the largest absolute number of individuals infected with HTLV-1/2, close to 2,500,000, and is also considered epidemic for HIV/Aids with a prevalence rate of 0.3%-0.6%. The routes of such retroviruses transmission could vary according to the region, population and period of study. This study aimed to characterize HTLV-1 and HTLV-2 that circulate in HIV-coinfected patients from the southern (n=34) and southeastern (n=20) Brazil. For analysis, sequencing of LTR, env and tax regions of HTLV-1 and HTLV-2 and bioinformatic tools were employed, and the results obtained analyzed according to geographic regions and risk factors. The results obtined confirmed HTLV-1a subtype, Transcontinental subgroup A as the prevalent, grouping into two Latin America clusters. The most frequent nucleotide substitution V1981I in the env and the Brazilian molecular signature in TaxA were detected. The HTLV-2a subtype, variant 2c (characteristic of the long Tax found in Brazilian strains) was detected in all except one isolate, as well the amino acid change S1909P in the env region. The HTLV-2 clustered according to geographic region and risk factors (sexual and IDU). All sequences are in GenBank. This study confirmed the double entrance of HTLV-1 in Brazil, and the presence of the Amerindian HTLV-2c in HIV-coinfected patients. The lack, in the present study, of the prototypic North American HTLV-2a and HTLV-2b subtypes circulating worldwide suggest the introduction of HTLV-2 before HIV-1 in such vulnerable population of Brazil. Support: MCT/CNPq # 481040/2007-2 and # 303545/2012-7, CAPES, IAL # 33/07 and # 39/07), Brazil.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.